Medical Device News Magazine

World’s 1st Healthcare Metaverse from DeHealth

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

A British non-profit organization, DeHealth, is revolutionizing the healthcare industry. The company announced the start of the creation of a Decentralized Metaverse, which will take millions of doctors and patients to a new world where they can work, interact with each other in full 3D format and earn virtual assets by selling their anonymized medical data.

The HLT (health) token will become the main mean of settlement within the ecosystem that will power it from the inside.

The DeHealth Metaverse will be an extension of the VR, AR, and Mixed Reality (MR) technologies. It will allow several participants, for instance, a doctor and a patient, to communicate via one virtual space, assimilating the real-world situation.

The user’s ability to transfer their digital identity (avatar), including all medical data collected through other digital platforms, into the new virtual world without problems will be critical to the success of the DeHealth metaverse.

Anna Bondarenko, the Co-Founder DeHealth commented: “Our goal is to provide people with the most advanced technologies to preserve their health so that every person in the world, regardless of the place of residence, social status, and financial capabilities, can control their health and life. The future of healthcare lies not in treatment but the prevention of diseases. Our AI will notice the slightest deviations from the human norm and warn about it. Thanks to HLT, each person in the metaverse can sell their impersonal medical information with their own hands.”

Denys Tsvaig, the Co-Founder of DeHealth, commented: “To implement our metaverse, we will use a new technological stack: the Hospital OS digital platform, the blockchain network (cryptoeconomics of the HLT Network), fundamentally different AR / VR devices, electronic clothing, 5G communication networks, quantum computing & communications, cybersecurity, data storage chips using synthetic biology and so much more. The metaverse may require a new programming model that resembles a living and open developing platform, where millions of users seamlessly move from one world to another using the avatar of themselves.”

The DeHealth metaverse will be supported by a wide range of devices – from smartphones and PCs to mixed types of headsets.

Holders of HTL tokens will become the first investors and leaders of the new trend in healthcare.

A preliminary version of the metaverse will be available in late 2022. It will open up access to 3 million Hospital OS users, DeHealth said.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”